Andrea C. Wickremasinghe, MD

Adjunct Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Wickremasinghe received undergraduate degrees in Biology and Psychology from the University of Missouri, Columbia. She received her Medical Degree from the University of Missouri, Columbia in 2007, and completed a residency in Pediatrics at the Mayo Clinic. She then went on to complete a fellowship in Neonatology at the University of California, San Francisco. She joined Kaiser Permanente in 2013.

Dr. Wickremasinghe's medical interests include neonatal hyperbilirubinemia and neurodevelopmental outcomes after prematurity.

Publications

  • Published 4/1/2023

    Wickremasinghe AC, Kuzniewicz MW, Walsh EM, Li S, Newman TB. NICU Versus Mother/Baby Unit Admission for Low-Acuity Infants Born at 35 Weeks' Gestation. Pediatrics. 2023 Apr 01; 151(4). PMID: 36994638.

    Read at: PubMed

  • Published 10/28/2020

    Clyman RI, Kaempf J, Liebowitz M, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Fernandez E, Sankar M, Leone T, Perez J, Serize A. Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial. J Pediatr. 2021 02; 229:283-288.e2. PMID: 32979387.

    Read at: PubMed

  • Published 6/27/2019

    Liebowitz M, Katheria A, Sauberan J, Singh J, Nelson K, Hassinger DC, Aucott SW, Kaempf J, Kimball A, Fernandez E, Carey WA, Perez J, Serize A, Wickremasinghe A, Dong L, Derrick M, Wolf IS, Heuchan AM, Sankar M, Bulbul A, Clyman RI. Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial. J Pediatr. 2019 10; 213:222-226.e2. PMID: 31255386.

    Read at: PubMed

  • Published 3/8/2019

    Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Wolf IS, Kimball A, Sankar M, Leone T, Perez J, Serize A, Clyman RI. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol. 2019 05; 39(5):599-607. PMID: 30850756.

    Read at: PubMed

  • Published 10/16/2018

    Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Fernandez E, Sankar M, Leone T, Perez J, Serize A. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019 02; 205:41-48.e6. PMID: 30340932.

    Read at: PubMed

Education

  • University of Missouri School of Medicine, MD
  • University of Missouri, BS